| 1 |
Drug repurposing strategies in the development of potential antifungal agents
Zhang Q, Liu FY, Zeng M, Mao YY, Song ZY
Applied Microbiology and Biotechnology, 105(13), 5259, 2021 |
| 2 |
Application of portable real-time recombinase-aided amplification (rt-RAA) assay in the clinical diagnosis of ASFV and prospective DIVA diagnosis
Wang ZH, Li P, Lin X, Jia H, Jiang YT, Wang XJ, Hou SH
Applied Microbiology and Biotechnology, 105(8), 3249, 2021 |
| 3 |
COVID19-clinical presentation and therapeutic considerations
Kenny G, Mallon PW
Biochemical and Biophysical Research Communications, 538, 125, 2021 |
| 4 |
Clinical applicability of optogenetic gene regulation
Wichert N, Witt M, Blume C, Scheper T
Biotechnology and Bioengineering, 118(11), 4168, 2021 |
| 5 |
Recent progress in the LC-MS/MS analysis of oxidative stress biomarkers
Andries A, Rozenski J, Vermeersch P, Mekahli D, Van Schepdael A
Electrophoresis, 42(4), 402, 2021 |
| 6 |
CE-MS for metabolomics: Developments and applications in the period 2018-2020
Zhang W, Ramautar R
Electrophoresis, 42(4), 381, 2021 |
| 7 |
Analysis of bile acids in human biological samples by microcolumn separation techniques: A review
Dosedelova V, Itterheimova P, Kuban P
Electrophoresis, 42(1-2), 68, 2021 |
| 8 |
Simultaneous quantification of Daclatasvir and Sofosbuvir in human plasma and pharmacokinetic study by LCMS/MS
Amarnath, Srivastava AK, Ameta SC, Ameta R
Indian Journal of Chemical Technology, 28(1), 47, 2021 |
| 9 |
Phytochemicals intended for anticancer effects at preclinical levels to clinical practice: Assessment of formulations at nanoscale for non-small cell lung cancer (NSCLC) therapy
Nguyen THP, Kumar VB, Ponnusamy VK, Mai TTT, Nhat PT, Brindhadevi K, Pugazhendhi A
Process Biochemistry, 104, 55, 2021 |
| 10 |
Staphylococcins: an update on antimicrobial peptides produced by staphylococci and their diverse potential applications
Bastos MDD, de Farias FM, Fagundes PC, Coelho MLV
Applied Microbiology and Biotechnology, 104(24), 10339, 2020 |
